1. Home
  2. GILT vs MYGN Comparison

GILT vs MYGN Comparison

Compare GILT & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • MYGN
  • Stock Information
  • Founded
  • GILT 1987
  • MYGN 1991
  • Country
  • GILT Israel
  • MYGN United States
  • Employees
  • GILT N/A
  • MYGN N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GILT Technology
  • MYGN Health Care
  • Exchange
  • GILT Nasdaq
  • MYGN Nasdaq
  • Market Cap
  • GILT 604.7M
  • MYGN 642.0M
  • IPO Year
  • GILT 1993
  • MYGN 1995
  • Fundamental
  • Price
  • GILT $11.28
  • MYGN $7.50
  • Analyst Decision
  • GILT Strong Buy
  • MYGN Hold
  • Analyst Count
  • GILT 2
  • MYGN 13
  • Target Price
  • GILT $11.00
  • MYGN $13.50
  • AVG Volume (30 Days)
  • GILT 853.3K
  • MYGN 1.4M
  • Earning Date
  • GILT 11-12-2025
  • MYGN 11-06-2025
  • Dividend Yield
  • GILT N/A
  • MYGN N/A
  • EPS Growth
  • GILT 12.49
  • MYGN N/A
  • EPS
  • GILT 0.39
  • MYGN N/A
  • Revenue
  • GILT $349,746,000.00
  • MYGN $832,900,000.00
  • Revenue This Year
  • GILT $47.18
  • MYGN $0.17
  • Revenue Next Year
  • GILT $13.80
  • MYGN $6.19
  • P/E Ratio
  • GILT $29.27
  • MYGN N/A
  • Revenue Growth
  • GILT 19.67
  • MYGN 3.83
  • 52 Week Low
  • GILT $4.54
  • MYGN $3.76
  • 52 Week High
  • GILT $11.60
  • MYGN $29.30
  • Technical
  • Relative Strength Index (RSI)
  • GILT 55.01
  • MYGN 68.28
  • Support Level
  • GILT N/A
  • MYGN $7.13
  • Resistance Level
  • GILT $11.06
  • MYGN $7.80
  • Average True Range (ATR)
  • GILT 0.34
  • MYGN 0.43
  • MACD
  • GILT -0.32
  • MYGN 0.06
  • Stochastic Oscillator
  • GILT 97.66
  • MYGN 85.15

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: